Come up with a name for your new list and we'll add to it:
Trevena raised a round of funding on August 18, 2011. Investors include
National Institutes of Health.
Trevena is a clinical stage pharmaceutical company focused on discovering and developing the next generation of G protein coupled receptor (GPCR) targeted medicines. Despite the past success of GPCR d…